CD40 and cancer: Further analysis revealed cancer group-specific activation of several important signalling pathways, including the CD40 pathway, which regulates immune response intensity; the SPP1 pathway, which mediates cell adhesion and microenvironment remodelling; and key signalling pathways, such as the VEGF and TGFβ pathways (Figure 6C).